IQ EQ FUND MANAGEMENT (IRELAND) Ltd
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1620943
DUBLIN 2, L2
Position in ADPT
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$414,333
+$414,333 QoQ
Shares Held
19,316
+4.5% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#23
of 70 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds $38,374,533 across 11 Diagnostics & Research names. ADPT ranks #10 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
50,524 | $8,883,634 | |
| 2 | NTRA |
Natera, Inc.
|
26,907 | $7,303,905 | |
| 3 | VCYT |
Veracyte, Inc.
|
97,158 | $5,706,089 | |
| 4 | PSNL |
Personalis, Inc.
|
351,741 | $4,713,329 | |
| 5 | WGS |
GeneDx Holdings Corp.
|
66,216 | $4,545,728 | |
| 6 | CDNA |
CareDx, Inc.
|
99,173 | $2,826,430 | |
| 7 | GH |
Guardant Health, Inc.
|
16,279 | $2,442,338 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
1,271 | $669,105 |
All Filings in ADPT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $414,333 | 77,265 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | — | 73,930 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | — | 64,259 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | — | 66,759 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | — | 50,104 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | — | 49,413 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | — | 35,521 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | — | 25,576 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | — | 19,750 | Shares | Sole | 2024-07-29 | |
| No filing history on record for this holder in this stock. | ||||||